arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

MYOMO, INC.

MYO
$1.42 ▲ +0.10 (+7.58%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
11 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
17
Health
Poor
Bearish
auto_awesome

Analytical Summary

MYOMO, INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $59.4M
Dividend Yield
Revenue Growth 25.7%
Op. Margin -35.2%
ROIC -65.8%
FCF / Share $-0.39
Trailing P/E
Price / Book 4.8x
FCF Yield
Debt / Equity 0.98
info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$40.93M
↑ +25.7%
Net Income Profit after all expenses
$-15.57M
↓ -151.9%
Operating Margin Operating profit as % of sales
-35.2%
↓ -84.5% 7th
FCF / Share Free cash flow per share
$-0.39
↓ -215.3%
Long-Term Debt Long-term obligations
$11.22M
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
6
Returns
6
Financial Health
21
Cash Quality
68

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 42 quarters